Omri Amirav-Drory
Fondateur chez Omri A.D Tech.Bio Ltd.
Profil
Omri Amirav-Drory, Ph.D.
is the General Partner at NFX Bio.
He is a scientist and an operator who has founded, scaled, and invested in some of today’s most important techbio companies.
Before becoming an investor, Omri was the Founding CEO of Genome Compiler, which developed software for genetic engineers and molecular and synthetic biologists.
He led the company to a successful acquisition by Twist Bioscience, a next-generation DNA synthesis company currently valued at ~$2.5 Billion.
Omri stayed at Twist for almost three years after the acquisition as the Head of Corporate Development.
After leaving Twist, Omri became the Founding Partner at Tech.Bio where he invested and advised in companies like Mammoth Biosciences, immunai, C2i Genomics, and more.
Now as an investor, Omri understands what it means to be a Scientist-CEO and is committed to a future where this is the norm, not the exception.
Postes actifs de Omri Amirav-Drory
| Sociétés | Poste | Début |
|---|---|---|
Omri A.D Tech.Bio Ltd.
 Omri A.D Tech.Bio Ltd. Investment ManagersFinance Omri AD Tech.Bio Ltd. was founded by Omri Amirav-Drory on September 17, 2019 and is headquartered in Herzliya, Israel. | Fondateur | 17/09/2018 |
NFX Capital Management LLC
 NFX Capital Management LLC Investment ManagersFinance NFX Capital Management LLC (NFX Capital) is a venture capital firm founded in 2015. The firm is headquartered in San Francisco, California. | Private Equity Investor | 01/12/2020 |
Talus Bioscience, Inc.
 Talus Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Talus Bioscience, Inc. is a company that aims to address the primary cause of cancer and other diseases, which is regulome dysfunction. The company is based in Seattle, WA, and recently raised 9.75 million in seed funding to support their efforts. The company is focused on developing a drug discovery platform that can rapidly measure and manipulate the regulome, providing a new approach to cancer therapeutics. The company has also hired a new COO, Michelle Briscoe. Talus Bioscience was founded by Alex Federation and Lindsay Pino, with Alex Federation serving as CEO since incorporation. | Directeur/Membre du Conseil | 01/12/2021 |
La Jolla Labs, Inc.
 La Jolla Labs, Inc. Miscellaneous Commercial ServicesCommercial Services La Jolla Labs, Inc. is a company that utilizes RNA biology, automation, cloud computing, and machine learning to provide innovative medical solutions to patients. The company is based in La Jolla, CA. The company specializes in various RNA-targeting modalities, such as splicing gapmers, miRNA, antisense oligonucleotides, and siRNA. The CEO of the company is Donald Jeff Milton. | Directeur/Membre du Conseil | 01/10/2021 |
Mana.Bio
 Mana.Bio Information Technology ServicesTechnology Services Mana.Bio operates as an AI based drug delivery company. The company was founded by Yogev Debbi and Roy Nevo and is headquartered in United States. | Directeur/Membre du Conseil | 01/10/2021 |
Pangea Therapeutics Ltd.
 Pangea Therapeutics Ltd. Medical/Nursing ServicesHealth Services Pangea Therapeutics Ltd. is an Israeli company that specializes in developing a proprietary tumor intelligence platform called Technology Enlight. The company is based in Tel Aviv, Israel. This platform enables a deeper understanding of how a tumor would respond to therapy by considering expression abnormalities, which are more common than actionable mutations. By combining these with tumor vulnerability maps, the platform uncovers many more clinically relevant insights than approaches based solely on genomic alterations. The company was founded by Eytan Ruppin, Eyal Gottlieb, Ze'ev Ronai. The CEO is Tuvik Beker. | Directeur/Membre du Conseil | 01/06/2021 |
Pepper Bio, Inc.
 Pepper Bio, Inc. Packaged SoftwareTechnology Services Pepper Bio, Inc. develops an AI-based drug discovery platform. The American company was founded by Samantha Dale Strasser and Yu Jon Hu, with Yu Jon Hu serving as the CEO since incorporation. | Directeur/Membre du Conseil | 01/02/2021 |
Nanocarry Therapeutics Ltd.
 Nanocarry Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Nanocarry Therapeutics Ltd. is a company based in Nes-Ziona, Israel. Nanocarry is developing a new class of therapeutics using bioengineered nanoparticles to treat oncology indications and brain diseases. The Israeli company's proprietary "plug and play" approach allows for easy modification to deliver a wide array of biologics safely and effectively to the brain and beyond. Nanocarry's first products in development are for brain metastases of HER2+ breast cancer and non-small cell lung cancer. The company aims to extend the reach of biological therapeutics to the brain to tackle CNS diseases head-on, pioneering a multidisciplinary approach that overcomes the blood-brain barrier. The company was founded by Rachela Popovtzer, Oshra Betzer, and Revital Mandil-Levin, with Revital Mandil-Levin serving as the CEO since incorporation. | Directeur/Membre du Conseil | 01/02/2021 |
Gilboa Therapeutics Ltd.
 Gilboa Therapeutics Ltd. BiotechnologyHealth Technology Gilboa Therapeutics Ltd. is a preclinical-stage biopharmaceutical company located in Israel. The Israeli company is focused on developing novel and high-impact, next-generation cancer immunotherapies that harness the power of a patient's own immune system to treat cancer, improve outcomes, and save lives. Gilboa's proprietary technology, solidt, is an engineered cell therapy that targets multiple different tumor types and is intended to be used in combination with a wide range of antigen-specific antibodies. The company is driven by a sense of urgency to discover, develop, and rapidly bring their game-changing new therapeutics to cancer patients in need, significantly improving outcomes and saving lives. | Directeur/Membre du Conseil | 01/01/2021 |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Omri Amirav-Drory
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | - |
Formation de Omri Amirav-Drory
| Stanford University | Doctorate Degree |
| Tel-Aviv University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TWIST BIOSCIENCE CORPORATION | Health Technology |
| Entreprise privées | 20 |
|---|---|
Genome Compiler Israel Ltd.
 Genome Compiler Israel Ltd. Data Processing ServicesTechnology Services Genome Compiler Israel Ltd. develops software for personalized synthetic genome design. It provides an intuitive all-in-one software platform for genetic engineers, molecular and synthetic biologists. The company was founded by Omri Amirav-Drory Nir Ben Moshe, Yogev Debbi and Roy Nevo in 2011 and is headquartered in Tel Aviv, Israel. | Technology Services |
Genome Compiler Corp.
 Genome Compiler Corp. Information Technology ServicesTechnology Services Genome Compiler Corp. provides software services. The firm’s software platform that enables genetic engineers, and molecular and synthetic biologists for DNA design and visualization, data management, and collaboration. The company was founded by Omri Amirav-Drory, Roy Nevo and Yogev Debbi in 2011 and is headquartered in Los Altos, CA. | Technology Services |
Omri A.D Tech.Bio Ltd.
Omri A.D Tech.Bio Ltd. Investment ManagersFinance Omri AD Tech.Bio Ltd. was founded by Omri Amirav-Drory on September 17, 2019 and is headquartered in Herzliya, Israel. | Finance |
NFX Capital Management LLC
NFX Capital Management LLC Investment ManagersFinance NFX Capital Management LLC (NFX Capital) is a venture capital firm founded in 2015. The firm is headquartered in San Francisco, California. | Finance |
Talus Bioscience, Inc.
Talus Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Talus Bioscience, Inc. is a company that aims to address the primary cause of cancer and other diseases, which is regulome dysfunction. The company is based in Seattle, WA, and recently raised 9.75 million in seed funding to support their efforts. The company is focused on developing a drug discovery platform that can rapidly measure and manipulate the regulome, providing a new approach to cancer therapeutics. The company has also hired a new COO, Michelle Briscoe. Talus Bioscience was founded by Alex Federation and Lindsay Pino, with Alex Federation serving as CEO since incorporation. | Commercial Services |
La Jolla Labs, Inc.
La Jolla Labs, Inc. Miscellaneous Commercial ServicesCommercial Services La Jolla Labs, Inc. is a company that utilizes RNA biology, automation, cloud computing, and machine learning to provide innovative medical solutions to patients. The company is based in La Jolla, CA. The company specializes in various RNA-targeting modalities, such as splicing gapmers, miRNA, antisense oligonucleotides, and siRNA. The CEO of the company is Donald Jeff Milton. | Commercial Services |
Mana.Bio
Mana.Bio Information Technology ServicesTechnology Services Mana.Bio operates as an AI based drug delivery company. The company was founded by Yogev Debbi and Roy Nevo and is headquartered in United States. | Technology Services |
Pangea Therapeutics Ltd.
Pangea Therapeutics Ltd. Medical/Nursing ServicesHealth Services Pangea Therapeutics Ltd. is an Israeli company that specializes in developing a proprietary tumor intelligence platform called Technology Enlight. The company is based in Tel Aviv, Israel. This platform enables a deeper understanding of how a tumor would respond to therapy by considering expression abnormalities, which are more common than actionable mutations. By combining these with tumor vulnerability maps, the platform uncovers many more clinically relevant insights than approaches based solely on genomic alterations. The company was founded by Eytan Ruppin, Eyal Gottlieb, Ze'ev Ronai. The CEO is Tuvik Beker. | Health Services |
Pepper Bio, Inc.
Pepper Bio, Inc. Packaged SoftwareTechnology Services Pepper Bio, Inc. develops an AI-based drug discovery platform. The American company was founded by Samantha Dale Strasser and Yu Jon Hu, with Yu Jon Hu serving as the CEO since incorporation. | Technology Services |
Nanocarry Therapeutics Ltd.
Nanocarry Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Nanocarry Therapeutics Ltd. is a company based in Nes-Ziona, Israel. Nanocarry is developing a new class of therapeutics using bioengineered nanoparticles to treat oncology indications and brain diseases. The Israeli company's proprietary "plug and play" approach allows for easy modification to deliver a wide array of biologics safely and effectively to the brain and beyond. Nanocarry's first products in development are for brain metastases of HER2+ breast cancer and non-small cell lung cancer. The company aims to extend the reach of biological therapeutics to the brain to tackle CNS diseases head-on, pioneering a multidisciplinary approach that overcomes the blood-brain barrier. The company was founded by Rachela Popovtzer, Oshra Betzer, and Revital Mandil-Levin, with Revital Mandil-Levin serving as the CEO since incorporation. | Commercial Services |
Gilboa Therapeutics Ltd.
Gilboa Therapeutics Ltd. BiotechnologyHealth Technology Gilboa Therapeutics Ltd. is a preclinical-stage biopharmaceutical company located in Israel. The Israeli company is focused on developing novel and high-impact, next-generation cancer immunotherapies that harness the power of a patient's own immune system to treat cancer, improve outcomes, and save lives. Gilboa's proprietary technology, solidt, is an engineered cell therapy that targets multiple different tumor types and is intended to be used in combination with a wide range of antigen-specific antibodies. The company is driven by a sense of urgency to discover, develop, and rapidly bring their game-changing new therapeutics to cancer patients in need, significantly improving outcomes and saving lives. | Health Technology |
Eleven Therapeutics Ltd.
 Eleven Therapeutics Ltd. Medical/Nursing ServicesHealth Services Eleven Therapeutics Ltd. is an Israeli biotech company that combines artificial intelligence, functional assays, and combinatorial chemistry to develop RNAi therapeutics. The company was founded in 2020 by a group of interdisciplinary scientists and has three collaborative hubs located in undisclosed locations. The company is based in an undisclosed location. Eleven Therapeutics is currently focused on developing siRNA treatments for respiratory diseases using its flagship invention, SCSI-RNA™. This fully programmable molecule is designed to address the delivery, durability, and efficacy challenges of any disease and biological target of interest. The company was founded by Erlich Yaniv, Shaun Ilan, Greg Hannon, and Erlich Yaniv has been the CEO since incorporation. | Health Services |
Light Bio, Inc.
 Light Bio, Inc. Information Technology ServicesTechnology Services Light Bio, Inc. engages in other technology industry. The company is headquartered in Mount Horeb, WI. | Technology Services |
C2i Genomics, Inc.
 C2i Genomics, Inc. Packaged SoftwareTechnology Services C2i Genomics, Inc. is engaged in the research and development on cancer. It provides ultrasensitive test for cancer. The company was founded by Asaf Zviran and Ezra Sofer in 2019 and is headquartered in New York, NY. | Technology Services |
Wild Biotech Ltd.
 Wild Biotech Ltd. Packaged SoftwareTechnology Services Wild Biotech Ltd. develops a drug discovery platform. The private company is based in Rehovot, Israel. The Israeli company was founded by Ido Bachelet, Neta Raab, and Doron Levin. The CEO is Neta Raab. | Technology Services |
| Armada Biosystems | |
ResistanceBio, Inc.
 ResistanceBio, Inc. BiotechnologyHealth Technology ResistanceBio, Inc. is a company that focuses on overcoming treatment-resistant cancer. The company is based in San Carlos, CA. The company's mission is to defeat this type of cancer by developing a novel class of multi-targeted oncology treatments called Resistance Suppressing Therapy (REST). ResistanceBio was founded by Nicholas Goldner and Christopher Bulow, with Nicholas Goldner serving as the CEO since incorporation. | Health Technology |
Immunai, Inc.
 Immunai, Inc. Packaged SoftwareTechnology Services Immunai, Inc. engages in decoding of immune system to improve health. It offers an immune profiling platform, which is used to advance research and development in checkpoint blockade, cancer cell therapy, and cancer vaccines. The company was founded by Noam Solomon, Luis Voloch, Danny Wells, Ansuman Satpathy and Dan R. Littman in December 2018 and is headquartered in New York, NY. | Technology Services |
Mammoth Biosciences, Inc.
 Mammoth Biosciences, Inc. Internet Software/ServicesTechnology Services Mammoth Biosciences, Inc. operates CRISPR-based platform for disease detection. The firm offers its services under the categories of bioinformatics, biotechnology, genetics, health diagnostics and life science. The company was founded by Ashley Tehranchi, Janice Chen, Jennifer A. Doudna, Lucas Harrington and Trevor Martin and is headquartered in South San Francisco, CA. | Technology Services |
Metabiotech Corp.
 Metabiotech Corp. Packaged SoftwareTechnology Services Metabiotech Corp. operates a platform technology for reading and fixing DNA. Its synthetic biology solutions accelerate the design-build-test cycle for biotechnology and bioengineering and genomics pipeline that discovers clinically actionable genetic information for human diseases. The company was founded by Tuval Ben-Yehezkel and is headquartered in San Jose, CA. | Technology Services |
